Stephanie Sy:
Amna, unlike in other countries, in the U.S., pharmaceutical companies set the prices of drugs with few restraints, which means in many cases we pay a lot more compared to, say, Canadians or Europeans.
The U.S. is where these companies make most of their profits, including those that go into research and innovation for new and better drugs. President Trump wants the prices Americans pay to be on par with the lowest prices paid in other nations.
For more on what his executive order could mean, I’m joined by Stacie Dusetzina of Vanderbilt University Medical Center.
Stacie, thank you so much for joining the “News Hour.”
As you know, there is bipartisan agreement that Americans pay too much for these drugs. Former President Biden made this a policy priority as well. What does today’s E.O. do, and do you think it could move the needle?
